Mosunetuzumab-axgb Injection

Mosunetuzumab-axgb injection may cause a serious or life-threatening reaction called cytokine release syndrome (CRS). A doctor or nurse will monitor you carefully during your infusions. Your doctor will increase the dose of mosunetuzumab-axgb gradually with each infusion to ensure you are tolerating it. If you miss a dose, you may have to start the dosing schedule over again. Tell your doctor if you have an inflammatory disorder or if you have or think you may have any type of infection now. If you experience any of the following symptoms during and after your infusion, tell your doctor immediately: fever (100.4°F or higher), chills, low blood pressure, fast or irregular heartbeat, tiredness or weakness, difficulty breathing, headache, confusion, anxiousness, dizziness, nausea or vomiting.

🔔 Why is this medication prescribed?

Mosunetuzumab-axgb injection is used to treat people with follicular lymphoma (FL; a slow-growing blood cancer) that has returned after being treated 2 or more times with other medications. Mosunetuzumab-axgb is in a class of medications called monoclonal antibodies. It works by killing cancer cells.

🔔 How should this medicine be used?

Mosunetuzumab-axgb injection comes as a solution (liquid) to be given intravenously (into the vein) by a doctor or nurse at a healthcare facility. It is usually given on days 1, 8 and 15 and then every 3 weeks thereafter for a minimum of 8 21-day cycles. You will be given different medications before treatment to help you tolerate mosunetuzumab-axgb injection.

Your doctor may delay or stop your treatment with mosunetuzumab-axgb, or treat you with additional medications, depending on your response to the medication and any side effects that you experience. Talk to your doctor about how you are feeling during your treatment.

🔔 Other uses for this medicine

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

See also  Dronedarone